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Abstract
Emerging evidence relates some nutritional factors to depression risk. However, there is a scarcity of longitudinal
assessments on this relationship.
Objective: To evaluate the association between fatty acid intake or the use of culinary fats and depression incidence in a
Mediterranean population.
Material and Methods: Prospective cohort study (1999–2010) of 12,059 Spanish university graduates (mean age: 37.5 years)
initially free of depression with permanently open enrolment. At baseline, a 136-item validated food frequency
questionnaire was used to estimate the intake of fatty acids (saturated fatty acids (SFA), polyunsaturated fatty acids (PUFA),
trans unsaturated fatty acids (TFA) and monounsaturated fatty acids (MUFA) and culinary fats (olive oil, seed oils, butter and
margarine) During follow-up participants were classified as incident cases of depression if they reported a new clinical
diagnosis of depression by a physician and/or initiated the use of antidepressant drugs. Cox regression models were used to
calculate Hazard Ratios (HR) of incident depression and their 95% confidence intervals (CI) for successive quintiles of fats.
Results: During follow-up (median: 6.1 years), 657 new cases of depression were identified. Multivariable-adjusted HR (95%
CI) for depression incidence across successive quintiles of TFA intake were: 1 (ref), 1.08 (0.82–1.43), 1.17 (0.88–1.53), 1.28
(0.97–1.68), 1.42 (1.09–1.84) with a significant dose-response relationship (p for trend = 0.003). Results did not substantially
change after adjusting for potential lifestyle or dietary confounders, including adherence to a Mediterranean Dietary
Pattern. On the other hand, an inverse and significant dose-response relationship was obtained for MUFA (p for trend = 0.05)
and PUFA (p for trend = 0.03) intake.
Conclusions: A detrimental relationship was found between TFA intake and depression risk, whereas weak inverse
associations were found for MUFA, PUFA and olive oil. These findings suggest that cardiovascular disease and depression
may share some common nutritional determinants related to subtypes of fat intake.
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Introduction
Depression affects about 151 million people worldwide [1]. In
2004, unipolar depression was the third leading cause of Disability
Adjusted Life Years (DALY’s) in the world and the main cause in
middle and high income countries [1].
Wide variations exist in the prevalence of depression across
countries, suggesting that disparities in the distribution of several
risk factors may determine this heterogeneity [2]. Between-country
differences in food habits could account for these differences.
Epidemiological evidence is accruing in recent years to support a
relationship between improved nutrition and better mental health
[3–7]. Many biological mechanisms give support also to this
relationship [8–11]. Surprisingly, in spite of the high prevalence of
mental disorders, little etiological longitudinal research has been
conducted to assess the relationship between nutrition and
depressive disorders [3,4,12].
Rising secular trends in the incidence of depressive disorders
have been paralleled by a dramatic change in the sources of fat in
the Western diet. This change mainly consists in the replacement
of polyunsaturated (PUFA) or monounsaturated fatty acids
(MUFA) by saturated fats (SFA) and trans-unsaturated fats
(TFA) [11]. In consistency with this trend, the so-called ‘‘Western’’
food pattern (rich in SFA and TFA and common in Northern
Europe and USA) has been reported as a relevant risk factor for
depression [13,14].
Suicide rates and lifetime prevalence of mental disorders in
Europe show higher levels in Northern countries and the
lowest levels in Southern Mediterranean countries [15,16].
Although recent trends point towards a progressive narrowing
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of between-countries differences, food choices of Northern and
Southern European countries differ mainly in the consumption
of two food items: olive oil and pulses, with very high
consumption in Southern Europe [17]. In a previous report
by our group, a higher adherence to the Mediterranean food
pattern (rich in legumes, fruits, vegetables, fish and cereals, but
low in meat and dairy products, and followed in Southern
Europe) was found to be inversely associated with the risk of
depression [18].
However, beyond adherence to an overall dietary pattern, little
is known about the effect of specific types of major fat sources on
depression risk. Usually, PUFA [19] and olive oil (OO) [20–22]
have been considered as healthy lipids because they reduce the
incidence of cardiovascular disease (CVD). Contrarily, SFA and,
specially, TFA are known risk factors for CVD [23]. There are
some reasons to expect that CVD and depression might share
some common determinants [24]. However, excepting for fish oils
or omega-3 (n-3) fatty acids, the influence of other fat subtypes on
depression risk has received only little attention. In trials using fish
oils for the treatment of depression, mood scores improved
significantly for both the fish oil group and the control group who
received OO [25]. A possible explanation was that both fish and
OO, or simply an increased fat intake, were equally effective
against depressive symptoms, because low fat diets may adversely
affect mood [9,26].
The aim of our study was to assess the role of dietary fat and fat
subtypes on depression occurrence in a Mediterranean prospective
cohort. To our knowledge, only a recent case-control study [27]
and two previous smaller cohorts [28,29] have analyzed the
association between fat subtypes and depression risk. Both
previous cohorts reported inverse associations with OO or oleic
acid.
Materials and Methods
Subjects
The ‘‘Seguimiento Universidad de Navarra’’ (SUN) Project is a
dynamic cohort study including only university graduates initiated
in December 1999 in Spain and patterned after the models of the
Nurses Health Study and the Health Professionals Follow-up
Study [23]. Its methods have been previously described elsewhere
[30,31]. Information is gathered biennially by mailed question-
naires. Up to August 2007, 18,004 subjects had completed the
baseline questionnaire. Subjects lost to follow up (n = 1,762), with
energy intake out of predefined limits (,800 Kcal/day or .4,000
Kcal/day in men and ,500 Kcal/day or .3,500 Kcal/day in
women) (n = 1,556), with a history of cancer or cardiovascular
disease at baseline (n = 1,120), and users of antidepressant
medication or with depression at baseline (n = 1,507), were
excluded. Finally 12,059 participants who had at least completed
Figure 1. Flow chart of participants. The SUN Project.
doi:10.1371/journal.pone.0016268.g001
Fat Intake and Depression
PLoS ONE | www.plosone.org 2 January 2011 | Volume 6 | Issue 1 | e16268
one follow-up questionnaire up to May 2010 were included in the
analyses (Figure 1).
The study was approved by the Institutional Review Board of
the University of Navarra. Written informed consent was not
requested to the participants. Voluntary completion of the first
questionnaire was considered to imply informed consent. Our
Institutional Review Board specifically approved this consent
process.
Exposure assessment
Dietary intake at baseline was assessed through a validated
semi-quantitative food-frequency questionnaire [32,33]. It showed
reasonably good validity for assessing fat intake (energy-adjusted
intraclass correlation coefficients for different types of fats versus
four 3-day food records ranged from 0.49 to 0.75) [33]. Nutrient
intakes were calculated using the latest available information
included in food composition tables for Spain. Adjustments of
nutrients were made for total energy intake by using the residuals
method [34]. The ratio n-3/n-6 was also computed [35].
Outcome assessment
A participant was defined as an incident case of depression if
he/she responded positively in a follow-up questionnaire to the
question: ‘Have you ever been diagnosed of depression by a
medical doctor?’ or who reported the habitual use of antidepres-
sant drugs in at least one of the follow-up questionnaires
completed after 2, 4, 6, 8 or 10 years. Antidepressant use was
ascertained though an open question in which the participants
reported their medication utilization.
A self-reported diagnosis of depression done by a physician has been
validated in a sub-sample of our cohort using the Structured Clinical
Interview for DSM-IV (SCID-I) as Gold Standard. The estimated
sensitivity and specificity were 0.37 and 0.96 respectively [36].
Covariate assessment
Information on medical, socio-demographic, anthropometric,
and life-style related variables were obtained from the baseline
questionnaire. Physical activity was assessed through a validated
physical activity questionnaire [37]. Adherence to the Mediterra-
nean Dietary Pattern (MDP) was assessed combining 8 items (fruits
and nuts, vegetables, fish, legumes, cereals, meat and meat
products, dairy and alcohol intake) [38]. To avoid overlapping
with our main exposure, we excluded the ratio MUFA/SFA item
from this score (the actual range in our study was from 0 to 8).
Statistics
Cox regression models were used to assess the relationship
between quintiles of total dietary fatty acids and culinary fats and
the incidence of depression using always the lowest quintile as
reference. Tests of linear trend across increasing quintiles were
conducted by assigning the medians to each quintile; this variable
was treated as continuous. The Cox model used age as the
underlying time variable. Birth date was used as the origin
variable, entry time was defined as age at recruitment. Exit time
was defined as age at diagnosis of depression for cases or age when
completing the last follow-up questionnaire or age at death
(whichever occurred first) for participants who did not develop
depression. We stratified the analyses by age (in 5-year intervals) to
control for calendar-period and birth cohort effects [39]. Other
potential confounders included in the multiple-adjusted model
were: sex, age, smoking, physical activity during leisure time, total
energy intake, and baseline body mass index (BMI). In separate
models, additional adjustments were made for adherence to the
MDP. We conducted sensitivity analyses, and repeated all the
analyses 1) after excluding early cases (in the two first years), 2)
after excluding late cases (after .8 years), 3) after excluding
participants reported taking antidepressant drugs but not a
physician diagnosis of depression.
Results
We assessed 5,038 men and 7,021 women. Mean age at
recruitment was 37.5 years (SD: 11.5). The main characteristics of
the study population according to extreme quintiles of dietary fat
intake are shown in Table 1.
Intakes of the different fat subtypes were positively correlated.
Intake of SFA was correlated with MUFA, PUFA and TFA
(Pearson correlation coefficients: 0.52, 0.15 and 0.73, respectively).
Total fat intake contributed for 36.7% of total energy intake.
MUFA was the major contributor to total energy intake (15.7%).
The lowest contribution was TFA (only 0.4%).
Overall, 657 incident cases of depression were identified during
the follow-up period with a total accrual of 68,694 person years.
Table S1 shows the association between fat intake and depression
risk. In multivariate-adjusted models, a significant inverse
association was found for the fifth vs. the first quintile of PUFA
intake with depression risk. Moreover, a significant inverse linear
trend was observed (p = 0.031). In fully adjusted model, a
borderline significant inverse dose-response relationship was
observed for MUFA intake (p for trend = 0.053). Contrarily,
TFA was associated with a higher risk. A substantial apparent
relative increment (48%) in depression risk was found for the fifth
vs. the first quintile of TFA, with a significant linear trend test
(p = 0.003). After adjusting for adherence to the MDP, the
association remained statistically significant (p for trend = 0.027).
Whereas butter consumption seemed to be associated with an
increased risk of depression, OO consumption was inversely
associated with depression risk (p for trend = 0.030). Even after
adjusting for the adherence to the MDP, a borderline significant
inverse trend remained for OO (p = 0.06) (Table 2).
Finally, no association was observed for n-3, n-6, n-3 from fish
or the ratio between n-3 vs n-6 fatty acids intake. Neither was
found for seed oils or margarine (data not shown).
Several sensitivity analyses were carried out to assess possible
sources of bias in the estimation of the association between TFA
intake and depression risk (Table 3). We repeated the analyses
after excluding cases of depression reported in the first 2 years of
follow up (n = 257) and the magnitude of the association for the
fifth vs. first quintile of intake was even stronger. After the
exclusion of cases reported after more than 8 years of follow-up
(n = 54) or cases defined only by antidepressant use (n = 174), the
association between TFA intake and depression risk remained of
similar magnitude of effect (relative reduction in risk around 25–
30%) though the conventional level of statistical significance was
lost in some models.
Discussion
A direct potentially harmful association of TFA intake with the
risk of depression was found in this Mediterranean cohort. The
magnitude of this association was robust and persisted after several
degrees of control for confounding and several sensitivity analyses.
We also showed an inverse dose-response relationship for total
PUFA and MUFA intake. An inverse association between olive oil
consumption and depression was also found, although this
relationship was attenuated after adjustment for the adherence
to a Mediterranean Dietary Pattern.
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To our knowledge, this is the first cohort study that has analyzed
such a broad spectrum of fat subtypes in relation to depression
risk. In consistency with our results, two previous smaller cohort
studies reported inverse associations between OO or oleic acid
intake and depressive symptoms or depression risk [28,29]. The
positive association for PUFA intake reported in those cohorts was
weak and might be related to methodological issues. The first
cohort [28] did not use clinical depression as outcome, but only
assessed changes in a 15-point geriatric depression scale. The other
cohort [29] had a relatively small sample size, high attrition rates
and used a dietary assessment method (a 24-hour dietary recall),
which is not considered the most adequate tool to assess usual
diets.
Low-grade inflammatory status is frequently present among
depressive patients [40,41]. Pro-inflammatory cytokines may
interfere with neurotransmitter metabolism, decrease plasma
tryptophan level, alter neurotransmitter messenger RNA, and
inhibit Brain-Derived-Neurotrophic-Factor (BDNF) expression
[42,43]. BDNF is a peptide critical for axonal growth, neuronal
survival, and synaptic plasticity and function. BDNF levels have
been reported to be reduced in patients with depression, and
antidepressants seem to up-regulate BDNF and other neurotroph-
ic and growth factors [44]. Neuroprotection is thought to be partly
mediated by endothelial-produced BDNF [45]. A profile of
fat subtypes that can promote a better endothelial function is
thought to protect against neuropsychological disorders, including
depression.
Our findings suggest that TFA intake, a well known risk factor
for CVD, might have also a detrimental effect on depression.
Depression and CVD seem to share some common mechanisms
Table 2. Association between culinary fats consumption (quintiles: Q1 to Q5) and depression*.
Olive oil intake (g/d) (%){ 2.8 (1.2) 7.3 (2.9) 11.0 (4.1) 20.6 (7.2) 28.0 (12.1)
cases/person-years 143/13,933 126/13,788 137/13,619 118/13,867 133/13,486
Crude rates/103{ 10.3 (8.7–12.1) 9.1 (7.7–10.9) 10.1 (8.5–11.9) 8.5 (7.1–10.2) 9.9 (8.3–11.7)
Multivariate-adjusted model (1) 1 (ref) 0.77 (0.60–1.00) 0.85 (0.65–1.10) 0.64 (0.49–0.84) 0.78 (0.60–1.01) 0.030
Additionally adjusted for MDP (2) 1 (ref) 0.78 (0.60–1.01) 0.87 (0.68–1.13) 0.66 (0.51–0.86) 0.80 (0.62–1.04) 0.060
Butter intake (g/d) (%){ 0 (0) 0.2 (0.1) 0.5 (0.1) 1.0 (0.4) 4.0 (1.3)
cases/person-years 128/13,976 124/13,569 132/13,510 130/13,625 143/14,014
Crude rates/103{ 9.2 (7.7–10.9) 9.1 (7.7–10.9) 9.8 (8.2–11.6) 9.5 (8.0–11.3) 10.2 (8.7–12.0)
Multivariate-adjusted model (1) 1 (ref) 1.07 (0.81–1.42) 1.23 (0.92–1.64) 1.16 (0.87–1.54) 1.30 (1.00–1.70) 0.076
Additionally adjusted for MDP (2) 1 (ref) 1.08 (0.81–1.42) 1.22 (0.92–1.63) 1.15 (0.86–1.53) 1.27 (0.97–1.67) 0.125
The SUN cohort 1999–2010.
doi:10.1371/journal.pone.0016268.t002
Table 1. Baseline characteristics according to extreme quintiles of olive oil consumption and specific types of fat intake, mean
(SD).
Characteristic OO PUFA TFA
Q1 Q5 Q1 Q5 Q1 Q5
Sex (% men) 59.9 26.0 40.7 43.7 40.1 45.5
Age at baseline (y) 37 (12) 38 (11) 38 (12) 36 (11) 40 (12) 35 (11)
BMI (kg/m2) 24 (3) 23 (4) 23 (3) 23 (4) 24 (4) 23 (3)
Smoking:
Ex smoker (%) 26.6 35.0 30.4 25.1 35.0 23.4
Current (%) 21.6 23.4 20.6 24.9 19.5 24.0
Marital status (% married) 46.4 54.9 54.0 46.9 54.4 43.8
Unemployed (%) 4.3 5.1 3.9 5.3 3.9 4.4
Leisure time physical activity (Mets-h/w) 28 (26) 23 (20) 27 (26) 23 (21) 27 (25) 24 (22)
Total energy intake (Kcal/d) 2686 (595) 2267 (509) 2616 (534) 2517 (615) 2607 (565) 2495 (574)
Mediterranean Dietary Pattern (0–8) 3.6 (1.6) 4.1 (1.6) 4.3 (1.5) 3.4 (1.6) 4.9 (1.4) 2.9 (1.5)
Total fat intake* 34.7 (6.3) 40.7 (6.8) 31.6 (6.0) 40.8 (5.8) 32.8 (6.9) 40.2 (5.4)
Saturated fat intake* 13.0 (3.3) 12.1 (3.0) 11.5 (3.4) 13.0 (3.0) 9.5 (2.4) 15.7 (2.9)
Monounsaturated fat intake* 13.6 (2.8) 19.8 (3.9) 13.2 (3.0) 17.4 (3.9) 14.4 (4.1) 16.9 (3.1)
Polyunsaturated fat intake* 5.4 (1.7) 5.4 (1.6) 3.5 (0.6) 7.6 (1.3) 5.1 (1.7) 5.3 (1.5)
Trans unsaturated fat intake* 0.4 (0.2) 0.3 (0.2) 0.3 (0.2) 0.4 (0.2) 0.2 (0.1) 0.6 (0.2)
OO: Olive oil; PUFA: Polyunsaturated fatty acids; TFA: Trans unsaturated fatty acids.
*Percentage of total energy intake.
doi:10.1371/journal.pone.0016268.t001
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leading to similar biological changes [46,47]. The adverse effects
of TFA on CVD are thought to be mediated by increases in
plasma concentrations of LDL-cholesterol, reductions in HDL-
cholesterol, pro-inflammatory changes, endothelial dysfunction,
and possibly by insulin resistance and displacement of essential
fatty acids from membranes [48,49]. Thus, since depression is
associated with modifications in proinflammatory cytokines and
also with endothelial cell signaling cascades alteration [50]
(endothelium is responsible for the synthesis and secretion of
BDNF [45,51]), some detrimental biological modifications
caused by TFA with respect to CVD risk could also be
responsible for a harmful effect of TFA on depression risk. To
our knowledge, the association between TFA and depression risk
had not been reported before. Our results support a relationship
between fat subtypes and depression which may parallel the well
known effects of the quality of lipid intake on CVD risk [23].
The present analysis was carried out among a sample in which
TFA intake was fairly low and where the two main sources of
TFA intake were natural foods (cheese and whole-fat milk
accounting both for 60% of the variability in total TFA intake,
R2 = 0.60). In spite of the low absolute average intake of TFA in
this cohort (TFA contributed only for a very small percentage of
total energy, approximately only 0.4%) a substantial relative
increment (48%) in depression risk was found for the highest
category of intake. So, the repercussion of these results might be
really important in other settings such as the American
population where TFA intake is by far higher (up to 2.5% of
total energy intake) [52,53] and in which the main sources of
TFA are artificial foods [54].
On the other hand, OO contains some bioactive polyphenols
with important anti-inflammatory properties [55]. The anti-
inflammatory capacity of OO could improve the function of the
endothelium [56–58]. Moreover, the antioxidant actions of extra
virgin OO components such as tyrosol are capable to restore the
intracellular antioxidant defences [59] decreased among depres-
sive patients. In fact, oxidative stress is associated to this pathology
[60]. Oleic acid represents approximately 72 percent of OO [55].
From oleic acid, the lipid oleamide can be biosynthesized.
Oleamide has important actions related to mood disorders, such
as the induction of sleep [61]. It also plays a role in the
maintenance of the physicochemical properties of membranes via
its ability to increase the delta-9 desaturase enzyme activity and
thus improving the binding of serotonin to its receptors [26,62].
Adherence to the MDP has been associated with lower
depression risk in a shorter follow-up of this cohort including
only 480 incident cases [18]. It could be thought that an elevated
adherence to the MDP among high OO users may at least
partially explain some of our results. Although some potential
overlaps between these results and those published before by our
cohort could have occurred, we do not consider this possibility as
probable, because we did not use at all TFA or olive oil as part of
the definition of MDP in our previous report. Moreover, only
small changes in the results were observed when the analyses were
adjusted for adherence to the MDP. The adjustment for the
adherence to this dietary pattern strengthens our results as we
were able to independently assess the contribution of particular
lipids to depression risk.
Unlike OO, butter, seed oils and margarine consumption was
very low in this population, resulting in low between-subject
variability and this lower consumption might contribute to explain
that no associations were found for them.
The lack of association between n-3, n-6, n-3 from fish and
depression risk, or between the ratio n-3:n-6 and depression risk in
our cohort has also been documented in recent literature
downplaying the importance of these fat subtypes or their ratio
on depression [63,64].
The dietary data analyzed in our study were exclusively those
assessed at baseline (one time point only). The nature of this
information imposed some constraints on the level of analysis that
we could accomplish. We acknowledge that we did not account for
any variation in dietary intake during the follow-up period.
Further studies are needed to complete this assessment using
repeated measurements of diet. Other potential limitations of our
study need to be addressed, such as the self-reporting of a clinical
diagnosis or the use of medication to define an incident case of
depression. However, since participants were highly educated and
committed to collaborate, we assumed that the proportion of
misreporting the diagnosis would be low. Our validation study
found very high specificity (0.96) for the self-reported diagnosis of
depression. Theoretically, with perfect specificity, even when non-
differential misclassification of disease because of low sensitivity
exists, this will not bias the relative risk estimate [65]. Although the
Table 3. Sensitivity analysis for the association between the several dietary fats intake (quintiles) and depression.*
Trans unsaturated fat intake Q1 Q2 Q3 Q4 Q5 P for trend
Excluding early cases (n = 11,802; cases = 400)
Multivariate-adjusted (1)
Additionally adjusted for MDP (2)
1 (ref)
1 (ref)
1.37 (0.93–2.00)
1.36 (0.92–1.99)
1.56 (1.07–2.26)
1.54 (1.05–2.24)
1.67 (1.15–2.41)
1.64 (1.12–2.39)
1.86 (1.30–2.66)
1.81 (1.24–2.65)
0.001
0.003
Excluding late cases (n = 12,005; cases = 603)
Multivariate-adjusted (1)
Additionally adjusted for MDP (2)
1 (ref)
1 (ref)
1.06 (0.80–1.41)
1.04 (0.78–1.38)
1.07 (0.80–1.42)
1.03 (0.77–1.38)
1.21 (0.92–1.60)
1.16 (0.87–1.55)
1.33 (1.01–1.74)
1.25 (0.93–1.67)
0.02
0.09
Excluding only antidepressant users (n = 11,885;
cases = 483)
Multivariate-adjusted (1)
Additionally adjusted for MDP (2)
1 (ref)
1 (ref)
1.11 (0.80–1.53)
1.09 (0.79–1.51)
1.14 (0.83–1.57)
1.12 (0.81–1.55)
1.19 (0.87–1.63)
1.16 (0.83–1.60)
1.33 (0.98–1.81)
1.28 (0.92–1.78)
0.06
0.13
TFA: Trans unsaturated fatty acids; MDP: Mediterranean Dietary Pattern.
*Hazard ratios estimated with Cox Regression and 95% confidence interval (95% CI) If the confidence interval does not include 1.00, the results are statistically
significant (two-tailed p,0.05).
(1): Model 1 additionally adjusted for smoking (non, former, current smoker and missing value), leisure time physical activity (in quintiles of MET score), total energy
intake (Kcal/day), and BMI (Kg/m2).
(2): Model 2: Model 1 additionally adjusted for adherence to the Mediterranean Dietary Pattern (excluding SFA/MUFA ratio).
doi:10.1371/journal.pone.0016268.t003
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validity and reliability of the food-frequency questionnaire have
been extensively evaluated, some degree of misclassification may
exist in the dietary assessment and over- or under-estimation of
true intake could have biased the estimates. However, being the
miss-classification most probably non-differential, the bias will be
probably towards the null. More importantly, participants with
sub-clinical depression at baseline might have changed their food
habits because of their mood disorder. But we believe that it is not
likely that reverse causality could have biased our results because
the exclusion of cases diagnosed during the first two years even
strengthened the magnitude of the observed association. On the
other hand, diet was collected at baseline and some of the cases of
depression were reported after 10 years of follow-up. For that
reason, the induction period for diet effect might be shorter than
the time of follow-up of these late cases. Nevertheless, the
exclusion of cases diagnosed after 8 or 10 years did not
substantially change the magnitude of the association.
Several strengths of our study also deserve to be mentioned,
such as its large sample size, its prospective design, the high
retention rate in a long-term follow-up, the multiple adjustments of
our estimates for potential confounders, the existence of published
validation studies of our methods, and the population of highly
educated participants who are able to provide information of high
quality.
In conclusion, our results showed a protection of cardioprotec-
tive fats (PUFA and MUFA) and a detrimental effect of TFA on
depression risk. However, our findings need to be confirmed by
further prospective studies and by trials.
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Table S1 MDP:Mediterranean Dietary Pattern. * Hazard
ratios estimated with Cox Regression and 95% confidence interval
(95% CI) If the confidence interval does not include 1.00, the
results are statistically significant (two-tailed p,0.05). { energy
adjusted median intake and percentage of total energy intake.
{ Crude rates and 95% confidence intervals. (1) Model 1: adjusted
for: sex, age (years), smoking (non, former, current smoker and
missing value), leisure time physical activity (in quintiles of MET
score), total energy intake (Kcal/day), and BMI (Kg/m2). (2)
Model 2: Model 1 additionally adjusted for adherence to the
Mediterranean Dietary Pattern (excluding SFA/MUFA ratio).
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